难治性肝性胸水与死亡率增加相关,且与肝硬化和难治性腹水相比在更低的MELD-Na时发生死亡
这项回顾性队列研究纳入2552例接受治疗性胸腔/腹腔穿刺的肝硬化退伍军人,其中177例难治性肝性胸水(RH)、422例难治性腹水(RA)。RH与肝脏相关死亡(LRD)风险显著高于RA(校正HR 4.63,95%CI 3.31-6.48),且在全部MELD-Na分层中均成立;RH患者LRD发生时MELD-Na低于RA(16.5 vs 21.82,p=0.002),但MELD 3.0更高(27.85 vs 22.48,p<0.0001)。结论认为RH在等效MELD-Na下LRD风险高于RA,MELD 3.0可能更好地预测RH的LRD风险。
要点
- RH患者LRD风险显著高于RA(校正HR 4.63,95%CI 3.31-6.48)。
- RH的LRD风险在所有MELD-Na分层中均高于RA。
- RH患者LRD发生时MELD-Na低于RA(16.5 vs 21.82,p=0.002),MELD 3.0更高(27.85 vs 22.48,p<0.0001)。
核心结论
- RH与LRD风险高于RA相关,且在等效MELD-Na下即已存在。
- MELD 3.0可能更好地预测RH的LRD风险。
研究设计与样本
- 回顾性队列研究,纳入肝硬化退伍军人。
- 纳入标准为RH或RA,从首次治疗性胸腔穿刺/腹腔穿刺随访至死亡或移植。
- 2552例接受治疗性胸腔/腹腔穿刺的肝硬化患者中,177例符合RH、422例符合RA。
- 主要结局为LRD,以非LRD或移植为竞争风险。
主要发现
- RH较RA的LRD风险显著更高(校正HR 4.63,95%CI 3.31-6.48)。
- MELD-Na<10分层:校正HR 4.08(95%CI 2.30-7.24)。
- MELD-Na 10-14.9分层:校正HR 5.68(95%CI 2.63-12.28)。
- MELD-Na 15-24.9分层:校正HR 4.14(95%CI 2.34-7.34)。
- MELD-Na≥25分层:校正HR 7.75(95%CI 2.99-20.12)。
关键数值与推荐
- 需1次胸腔穿刺者较RA的LRD校正HR 3.54(95%CI 2.29-5.48)。
- 需2-3次胸腔穿刺者较RA的LRD校正HR 4.39(95%CI 2.91-6.63)。
- 需≥4次胸腔穿刺者较RA的LRD校正HR 7.89(95%CI 4.82-12.93)。
- RH与RA基线MELD-Na相似,但LRD发生时RH的MELD-Na为16.5 vs RA的21.82(p=0.002)。
- LRD发生时RH的MELD 3.0为27.85 vs RA的22.48(p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although refractory hepatic hydrothorax (RH) is a serious complication of cirrhosis, waitlisted patients do not receive standardized Model for End-stage Liver Disease (MELD) exemption because of inadequate evidence suggesting mortality above biochemical MELD. This study aimed to examine liver-related death (LRD) associated with RH compared to refractory ascites (RA). APPROACH AND RESULTS: This was a retrospective cohort study of Veterans with cirrhosis. Eligibility criteria included participants with RH or RA, followed from their first therapeutic thoracentesis/second paracentesis until death or transplantation. The primary outcome was LRD with non-LRD or transplantation as competing risk. Of 2552 patients with cirrhosis who underwent therapeutic thoracentesis/paracentesis, 177 met criteria for RH and 422 for RA. RH was associated with a significantly higher risk of LRD (adjusted HR [aHR] 4.63, 95% CI 3.31-6.48) than RA overall and within all MELD-sodium (MELD-Na) strata (<10 aHR 4.08, 95% CI 2.30-7.24, 10-14.9 aHR 5.68, 95% CI 2.63-12.28, 15-24.9 aHR 4.14, 95% CI 2.34-7.34, ≥25 aHR 7.75, 95% CI 2.99-20.12). LRD was higher among participants requiring 1 (aHR 3.54, 95% CI 2.29-5.48), 2-3 (aHR 4.39, 95% CI 2.91-6.63), and ≥4 (aHR 7.89, 95% CI 4.82-12.93) thoracenteses relative to RA. Although participants with RH and RA had similar baseline MELD-Na, LRD occurred in RH versus RA at a lower MELD-Na (16.5 vs. 21.82, p =0.002) but higher MELD 3.0 (27.85 vs. 22.48, p <0.0001). CONCLUSIONS: RH was associated with higher risk of LRD than RA at equivalent MELD-Na. By contrast, MELD 3.0 may better predict risk of LRD in RH.
引用
- Chin A, Bastaich DR, Dahman B, et al. Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites. Hepatology. 2023. PMID: 37625139. doi:10.1097/HEP.0000000000000577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。